Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation, reward, and stress. However, the role of hypocretins in addiction-related behaviors remains largely unexplored. Here we show that intracerebroventricular infusions of Hcrt-1 lead to a dose-related reinstatement of cocaine seeking without altering cocaine intake in rats. Hcrt-1 also dramatically elevates intracranial self-stimulation thresholds, indicating that, unlike treatments with reinforcing properties such as cocaine, Hcrt-1 negatively regulates the activity of brain reward circuitries. Hypocretin-induced reinstatement of cocaine seeking was prevented by blockade of noradrenergic and corticotropin-releasing factor systems, suggesting that Hcrt-1 reinstated drug seeking through induction of a stress-like state. Consistent with this interpretation, the selective Hcrt-1 receptor antagonist SB-334867 blocked footshock-induced reinstatement of previously extinguished cocaine-seeking behavior. These findings reveal a previously unidentified role for hypocretins in driving drug seeking through activation of stress pathways in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additional studies demonstrate that intraventricular Hcrt-1 elevates intracranial self-stimulation thresholds, suggesting an aversive effect of excessive activation of the Hcrt system (Boutrel et al., 2005).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Boutrel et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Shaffer, J. P. (1995) · Annual Review of Psychology · doi:10.1146/annurev.ps.46.020195.003021 · Cited by 1,960
Research works printed but not linked: 5
- 10.1097/00075197-200307000-00001 · doi:10.1097/00075197-200307000-00001
- Boutrel, B., Kenny, P. J., Markou, A. & Koob, G. F. (2005) in Hypocretins: Integrators of Physiological Functions, eds. de Lecea, L. & Sutcliffe, J. G. (Springer, New York), pp. 315-324.
- Kornetsky, C. & Esposito, R. U. (1979) Fed. Proc. 38**,** 2473-2476. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/488370/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Fed.%20Proc.&volume=38&publication_year=1979&pages=2473&pmid=488370&)]
- 10.1037/1064-1297.6.3.255 · doi:10.1037/1064-1297.6.3.255
- Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S. & van den Pol, A. N. (1999) J. Comp. Neurol. 415**,** 145-159. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10545156/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J.%20Comp.%20Neurol.&volume=415&publication_year=1999&pages=145&pmid=10545156&)] · doi:10.1002/(sici)1096-9861(19991213)415:2<145::aid-cne1>3.0.co;2-2
Cited by
Items 301–400 of 526
Tunisi, L., D’Angelo, L., Fernández-Rilo, A. C., Forte, N. R., Piscitelli, F., Imperatore, R., de Girolamo, P., Marzo, V. D., & Cristino, L. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.622405 · Cited by 29
“, 2017) could explain the enhancement of orexinergic tone associated with the pathological hyperarousal typical of compulsive and addictive behaviors (Boutrel et al., 2005).”
BackgroundOi, N., Suzuki, M., Terauchi, T., Tokunaga, M., Nakatani, Y., Yamamoto, N., Fukumura, T., Zhang, M., Suhara, T., & Higuchi, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400772t · Cited by 28
A Framework for Quantitative Modeling of Neural Circuits Involved in Sleep-to-Wake Transition
Sorooshyari, S. K., Huerta, R., & de Lecea, L. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00032 · Cited by 30
Alijanpour, S., Khakpai, F., Ebrahimi-Ghiri, M., & Zarrindast, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.033 · Cited by 27
Food for Thought: Understanding the Multifaceted Nature of Orexins
Sellayah, D., & Sikder, D. S. (2013) · Endocrinology · doi:10.1210/en.2013-1488 · Cited by 29
“influences on the reward system (15), drug addiction (16),”
BackgroundImpaired hypocretin/orexin system alters responses to salient stimuli in obese male mice
Tan, Y. C., Hang, F., Liu, Z.-W., Stoiljković, M., Wu, M., Tu, Y., Han, W., Lee, A. M., Kelley, C., Hajós, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130889 · Cited by 27
Cross-talk between the HPA axis and addiction-related regions in stressful situations
Nikbakhtzadeh, M., Ranjbar, H., Moradbeygi, K., Zahedi, E., Bayat, M., Soti, M., & Shabani, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15525 · Cited by 27
“The induction of a stress-like state by orexin results in the reinstatement of cocaine seeking [123].”
BackgroundHypocretin/Orexin Involvement in Reward and Reinforcement
España, R. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394623-2.00010-x · Cited by 26
“Consistent with this, SB-334967 reduces cue-induced reinstatement of ethanol and cocaine seeking (Lawrence et al., 2006; Smith et al., 2009) and reinstatement of cocaine-seeking following foot shock and yohimbineinduced stress (Boutrel et al., 2005; Richards et al., 2008).”
InfluentialOrexin: a gatekeeper of addiction
Carr, D., & Kalivas, P. W. (2006) · Nature Medicine · doi:10.1038/nm0306-274 · Cited by 26
Hata, T., Chen, J., Ebihara, K., Date, Y., Ishida, Y., & Nakahara, D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07808.x · Cited by 25
“…factor system Our findings not only replicated those of a previous report, which showed that i.c.v. injection of Orx-A increased the ICSS threshold (Boutrel et al., 2005), but also extended these observations by demonstrating for the first time that intra-VTA administration of Orx-A also increased…”
BackgroundMethodResultInfluentialTargeting the Orexin System for Prescription Opioid Use Disorder
Matzeu, A., & Martin‐Fardon, R. (2020) · Brain Sciences · doi:10.3390/brainsci10040226 · Cited by 26
“Because OrxA has been found to decrease the excitability of brain reward systems in the LH [49], it is possible that alterations of Orx expression may also be involved in negative affective states that are associated with opioid withdrawal and abstinence, which may be important in the modulation of opioid-seeking beha…”
Self-citationCorticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional Consequences
Slater, P. G., Yarur, H. E., & Gysling, K. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104927 · Cited by 27
“The neuropeptide orexin-A (OX-A) has also been involved in relapse to cocaine seeking (Boutrel et al., 2005).”
BackgroundRen, X., Lutfy, K., Mangubat, M., Ferrini, M. G., Lee, M. L., Liu, Y., & Friedman, T. C. (2013) · Journal of Obesity · doi:10.1155/2013/764742 · Cited by 27
Zhou, W.-L., Gao, X.-B., & Picciotto, M. R. (2015) · eneuro · doi:10.1523/eneuro.0052-14.2015 · Cited by 24
Williams, J. T., Bolli, M. H., Brotschi, C., Sifferlen, T., Steiner, M. A., Treiber, A., Gatfield, J., & Boss, C. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01894 · Cited by 24
Carvajal, F., Alcaráz-Iborra, M., Lerma-Cabrera, J. M., Valor, L. M., de la Fuente, L., Sanchez-Amate, M. D. C., & Cubero, I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.046 · Cited by 24
Łupina, M., Tarnowski, M., Baranowska‐Bosiacka, I., Talarek, S., Listos, P., Kotlinska, J. H., Gutowska, I., & Listos, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0993-0 · Cited by 24
“It also inhibited the stress-induced [31] and the environment-induced [32]”
BackgroundEdalat, P., Kavianpour, M., Zarrabian, S., & Haghparast, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.016 · Cited by 24
Pan, Y.-P., Liu, C., Liu, M., Wang, Y., Bian, K., Xue, Y., & Chen, L. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102019 · Cited by 26
Simmons, S. J., Martorana, R. M., Philogene-Khalid, H. L., Tran, F. H., Gentile, T. A., Xu, X., Su, S. H., Rawls, S. M., & Muschamp, J. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4709-3 · Cited by 23
“…by systemic or intraVTA injection reduces motivated responding and reinstated reward-seeking behavior for palatable reinforcers including self-administered cocaine (Bentzley and Aston-Jones 2015; Borgland et al. 2009; Boutrel et al. 2005; James et al. 2011; Muschamp et al. 2014; Smith et al. 2010).”
James, M. H., Yeoh, J. W., Graham, B. A., & Dayas, C. V. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-008 · Cited by 22
Sahafzadeh, M., Karimi‐Haghighi, S., Mousavi, Z., & Haghparast, A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.008 · Cited by 22
“A mechanism by which stress can influence relapse for drug seeking (Boutrel et al., 2005).”
BackgroundAscending orexinergic pathways and alcohol-seeking
Brown, R. M., & Lawrence, A. J. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.014 · Cited by 22
“Thus, overall, the role for OX1 receptor signalling across multiple modalities of ethanol-seeking is in support with findings regarding other drugs of abuse and supports a role for OX1 receptors in the learning of drug-cue associations and drug-seeking elicited by external stimuli [17,18].”
ResultDisubstituted piperidines as potent orexin (hypocretin) receptor antagonists
Jiang, R., Song, X., Bali, P., Smith, A. M., Bayona, C. R., Lin, L., Cameron, M. D., McDonald, P. H., Kenny, P. J., & Kamenecka, T. M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.122 · Cited by 23
Self-citationTransient targeting of hypothalamic orexin neurons alleviates seizures in a mouse model of epilepsy
Li, H., Viskaitis, P., Bracey, E. F., Peleg‐Raibstein, D., & Burdakov, D. (2024) · Nature Communications · doi:10.1038/s41467-024-45515-5 · Cited by 21
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Mohammadkhani, A., Mitchell, C. S., James, M. H., Borgland, S. L., & Dayas, C. V. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17325 · Cited by 23
“Orexin-induced drug-seeking behaviour can be blocked by adrenoceptor and CRF receptor antagonists, thus highlighting an important role of orexin in coordinating motivated behaviours in response to stress (Boutrel et al., 2005).”
Experience‐dependent plasticity in hypocretin/orexin neurones: re‐setting arousal threshold
Gao, X., & Wang, A. H. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02047.x · Cited by 21
“…required for behaviours critical to the survival of individuals and species, e.g. foraging for food, staying awake in an adverse environment, craving for rewards and memory formation (Yamanaka et al. 2003, Selbach et al. 2004, WinskySommerer et al. 2004, Boutrel et al. 2005, Harris et al. 2005).”
BackgroundBinge Eating in Female Rats Induced by Yo-Yo Dieting and Stress
Cifani, C., Bonaventura, M. V. M. D., Ciccocioppo, R., & Massi, M. (2012) · Neuromethods · doi:10.1007/978-1-62703-104-2_3 · Cited by 21
Mediavilla, C., Cabello, V., & Risco, S. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.021 · Cited by 21
The role of leptin in the regulation of neuroendocrine function and CNS development
Louis, G. W., & Myers, M. G. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9043-3 · Cited by 24
“Since the LHA is a critical regulator of the mesolimbic DA system [72, 74, 78–81], LRb-expressing neurons in the LHA might also contribute to the regulation of the mesolimbic DA system by leptin.”
BackgroundLinehan, V., Trask, R. B., Briggs, C., Rowe, T. M., & Hirasawa, M. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12967 · Cited by 20
“Orexins are also involved in neuronal and behavioural responses to drugs of abuse (Georgescu et al., 2003; Boutrel et al., 2005; Harris et al., 2005; Borgland et al., 2006; Narita et al., 2006), which may be mediated by DA neurons in the ventral tegmental area (VTA) (Kenny, 2011).”
BackgroundSun, W. (2011) · Current Drug Abuse Reviews · doi:10.2174/1874473711104040270 · Cited by 23
“Involvement of orexin in stress-induced reinstatement appears to depend on activation of the CRF system [71] suggesting that the effect of stress may involve an interaction between the orexin and CRF systems.”
BackgroundInfluentialSingh, R. P., & Biswas, D. A. (2023) · Cureus · doi:10.7759/cureus.34009 · Cited by 21
“Stress-induced cravings for alcohol and cocaine can be effectively suppressed by administering an OX1R antagonist [79-81].”
BackgroundDang‐Vu, T. T., Desseilles, M., Schwartz, S., & Maquet, P. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709788921708 · Cited by 20
Greene, E., Khaldi, S., Ishola, P., Bottje, W. G., Ohkubo, T., Anthony, N. B., & Dridi, S. (2015) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2015.08.016 · Cited by 19
Perrey, D. A., Decker, A. M., Li, J., Gilmour, B. P., Thomas, B. F., Harris, D. L., Runyon, S. P., & Zhang, Y. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.013 · Cited by 19
From Molecule to Behavior: Hypocretin/orexin Revisited From a Sex-dependent Perspective
Gao, X., & Horváth, T. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab042 · Cited by 20
“In addition to triggering drug addiction relapses (158), the Hcrt/Orx cells are responsible for coping with acute stressors (49, 179, 180).”
BackgroundInfluentialZarepour, L., Komaki, A., Shahidi, ., Sarihi, A., & Haghparast, A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.03.018 · Cited by 18
Recent progress in orexin/hypocretin physiology and pharmacology
Kukkonen, J. P. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2012-0013 · Cited by 18
“Similar was seen by de Lecea and coworkers with respect to cocaine-seeking and stress-induced relapse (102) .”
ResultPutula, J., Turunen, P. M., Johansson, L., Näsman, J., Ra, R., Korhonen, L., & Kukkonen, J. P. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.020 · Cited by 18
Flores‐Ramirez, F. J., Matzeu, A., Sánchez‐Marín, L., & Martin‐Fardon, R. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109046 · Cited by 18
Self-citationRegulation of morphine reward and feeding by CREB in the lateral hypothalamus
Olson, V. G., Green, T. A., Neve, R. L., & Nestler, E. J. (2006) · Synapse · doi:10.1002/syn.20344 · Cited by 18
“Finally, recent studies have established a role for orexin-expressing neurons in the LH in opiate reward (Harris et al., 2005) and in modulating stress regulation of opiate reward (Boutrel et al., 2005).”
BackgroundOrexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss–Webster mice
Riday, T. T., Fish, E. W., Robinson, J. E., Jarrett, T. M., McGuigan, M. M., & Malanga, C. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.003 · Cited by 20
“…projecting from the lateral hypothalamus (LH) to the mesencephalic ventral tegmental area (VTA; (Peyron et al. 1998) have been shown to be involved in drug preference (Harris et al. 2005) and reinstatement of drug selfadministration following extinction (Boutrel et al. 2005; Smith et al. 2009).”
BackgroundInfluentialPharmacological investigations of a yohimbine–impulsivity interaction in rats
Mahoney, M. K., Barnes, J. H., Wiercigroch, D., & Olmstead, M. C. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000251 · Cited by 19
“, 2010) and orexin1 receptor activity enhances stressinduced drug intake and reinstatement of drug seeking (Boutrel et al., 2005; Lawrence et al., 2006; Gilpin et al., 2008; Von Der Goltz et al., 2011).”
BackgroundChronic ketamine abuse is associated with orexin-A reduction and ACTH elevation
Huang, M., Chen, C.-H., Chen, L., Chang, H., Chen, C.-K., Lin, S., & Xu, K. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05342-9 · Cited by 17
A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging
Bai, P., Bai, S., Placzek, M. S., Lü, X., Fiedler, S. A., Ntaganda, B., Wey, H., & Wang, C. (2020) · Molecules · doi:10.3390/molecules25051018 · Cited by 17
“Therapeutics targeting the orexin system have been investigated for various brain disorders such as insomnia [1,3], cluster headache [13], substance abuse [4,14], and maladaptation to stress [15,16].”
BackgroundHypothalamic Control of Forelimb Motor Adaptation
Donegan, D., Kanzler, C. M., Büscher, J., Viskaitis, P., Bracey, E. F., Lambercy, O., & Burdakov, D. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0705-22.2022 · Cited by 19
Veisi, A., Khaleghzadeh‐Ahangar, H., Fattahi, M., & Haghparast, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03793-9 · Cited by 17
State-dependent control of lumbar motoneurons by the hypocretinergic system
Yamuy, J., Fung, S. J., Xi, M.-C., & Chase, M. H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.020 · Cited by 17
Prasad, A. A., & McNally, G. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110385 · Cited by 17
“For example, (OX1R) antagonists attenuate stress [36,37] and cueinduced [35,38,39] reinstatement of alcohol or cocaine seeking.”
BackgroundStettner, G. M., Kubin, L. K., & Volgin, D. V. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.028 · Cited by 17
“The dose and method of administration were selected based on previous studies [16,23,24].”
Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse
Baimel, C., & Borgland, S. L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_44 · Cited by 17
Hypocretin (Orexin) Replacement Therapies
Seigneur, E. M., & de Lecea, L. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100070 · Cited by 16
“Additional studies have shown that ICV infusion of Hcrt-1 into the VTA or into the lateral ventricles reinstated previously extinguished cocaineseeking behavior in rats [16,26].”
BackgroundPerrey, D. A., German, N., Decker, A. M., Thorn, D. A., Li, J., Gilmour, B. P., Thomas, B. F., Harris, D. L., Runyon, S. P., & Zhang, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500330v · Cited by 16
Azizbeigi, R., & Haghparast, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.029 · Cited by 16
Alcaráz-Iborra, M., & Cubero, I. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.04.012 · Cited by 17
Simmons, S. J., & Gentile, T. A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.02.026 · Cited by 16
“The first studies to examine hcrt/ox in the specific context of psychostimulant abuse were published in 2005 (Boutrel et al. 2005; Harris et al. 2005).”
BackgroundStrickland, J. C., Hatton, K. W., Hays, L. R., Rayapati, A. O., Lile, J. A., Rush, C. R., & Stoops, W. W. (2023) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000731 · Cited by 15
Zarmehri, H. A., Semnanian, S., & Fathollahi, Y. (2008) · Cited by 15
Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys
Foltin, R. W., & Evans, S. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.018 · Cited by 15
“Few studies have examined the effects of the peptide hypocretin-1 on cocaine selfadministration (Boutrel et al., 2005; España et al., 2011).”
BackgroundOrexin facilitates the ventilatory and behavioral responses of rats to hypoxia
Spinieli, R. L., Musa, R. B., Cornelius-Green, J. N., Hasser, E. M., & Cummings, K. J. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00334.2021 · Cited by 15
Oonk, M., Krueger, J. M., & Davis, C. J. (2016) · SLEEP · doi:10.5665/sleep.5984 · Cited by 15
Amirteymori, H., Karimi‐Haghighi, S., Mirmohammadi, M., Majidinezhad, M., Khosrowabadi, E., & Haghparast, A. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110616 · Cited by 14
Optogenetic and pharmacological interventions link hypocretin neurons to impulsivity in mice
Tyree, S. M., Jennings, K. J., Gonzalez, O. C., Li, S., Nicholson, J. R., von Heimendahl, M., & de Lecea, L. (2023) · Communications Biology · doi:10.1038/s42003-023-04409-w · Cited by 14
Utility of ‘substance use disorder’ as a heuristic for understanding overeating and obesity
O’Connor, R. M., & Kenny, P. J. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110580 · Cited by 15
Self-citationAzizbeigi, R., Farzinpour, Z., & Haghparast, A. (2018) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.130 · Cited by 15
“While the intracerebroventricular infusion of an OX1R antagonist suppresses footshock-induced reinstatement of cocaine seeking (Boutrel et al., 2005), intra-VTA”
The influence of orexins on ethanol-induced behavioral sensitization in male mice
Macedo, G. C., Kawakami, S. E., Vignoli, T., Sinigaglia‐Coimbra, R., & Suchecki, D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.07.010 · Cited by 13
“SB334867 also blocks cue-, stress- or orexin-A-induced reinstatement of cocaine- [3,37,41] and nicotine-seeking behavior [27].”
BackgroundKosse, C., & Burdakov, D. (2018) · eNeuro · doi:10.1523/eneuro.0012-18.2018 · Cited by 14
“generalized (cortical and sympathetic) arousal and net energy use; their hypoactivity evokes energy conservation, weight gain, and pathologic intermixing of sleep and wakefulness, and their hyperactivity is associated with stress and anxiety (Chemelli et al., 1999; Hara et al., 2001; Boutrel et al., 2005; Suzuki et al…”
BackgroundK+ channels stimulated by glucose: a new energy-sensing pathway
Burdakov, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0189-8 · Cited by 17
“Centrally administered orexin promotes anxiety-like behaviour [71], reinstates drug-seeking through induction of a stress-like state, and induces a longlasting brain reward deficit [10].”
BackgroundSleep deprivation engages the orexin/hypocretin system to regulate food reward seeking
Rojo, A. L. A., Barnhardt, T. R., Pham, T. Q., Heim, B., Cai, L., Tseng, G. C., & Huang, Y. H. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf047 · Cited by 12
Activity-Dependent Epigenetic Remodeling in Cocaine Use Disorder
López, A. J., Siciliano, C. A., & Calipari, E. S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_257 · Cited by 13
García‐Brito, S., Aldavert-Vera, L., Huguet, G., Kádár, E., & Segura-Torres, P. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107188 · Cited by 14
Therapeutics for alcoholism: what's the future?
Lawrence, A. J. (2007) · Drug and Alcohol Review · doi:10.1080/09595230601036937 · Cited by 12
Orexin-mediated motivated arousal and reward seeking
Bjorness, T. E., & Greene, R. W. (2024) · Peptides · doi:10.1016/j.peptides.2024.171280 · Cited by 12
The Molecular Mechanisms of Reward
Winstanley, C. A., & Nestler, E. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00004-8 · Cited by 11
Aldridge, G. M., Zarin, T. A., Brandner, A. J., George, O., Gilpin, N. W., Repunte‐Canonigo, V., Sanna, P. P., Koob, G. F., Vendruscolo, L. F., & Schmeichel, B. E. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100028 · Cited by 11
Self-citationGillman, A. G., Leffel, J. K., Kosobud, A., & Timberlake, W. D. (2013) · Chronobiology International · doi:10.3109/07420528.2013.782314 · Cited by 12
Emerging targets for addiction neuropharmacology
Ubaldi, M., Cannella, N., & Ciccocioppo, R. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.018 · Cited by 12
“OX1 has been implicated in the modulation of morphine, cocaine, nicotine, and alcohol seeking (Borgland et al., 2006; Boutrel et al., 2005; Cannella et al., 2009a; Dayas et al., 2008; Harris et al., 2005, 2007; Hollander et al., 2008; Jupp et al., 2011; Kallupi et al., 2010; Lawrence et al., 2006;…”
Farahimanesh, S., Moradi, M., Nazari-Serenjeh, F., Zarrabian, S., & Haghparast, A. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000381 · Cited by 12
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
Zhou, L., Sun, W., & See, R. E. (2011) · Pharmaceuticals · doi:10.3390/ph4060804 · Cited by 11
“Both intracerebroventricular (icv) and intra-VTA administration of OXA reinstate extinguished cocaine-seeking in animals with a prior history of cocaine self-administration [55,56].”
BackgroundDrug addiction co-morbidity with alcohol: Neurobiological insights
McGinn, M. A., Pantazis, C. B., Tunstall, B. J., Marchette, R. C. N., Carlson, E. R., Said, N., Koob, G. F., & Vendruscolo, L. F. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.002 · Cited by 12
Self-citationIllenberger, J. M., Flores‐Ramirez, F. J., Pascasio, G., Franco, M., Mendonsa, B., & Martin‐Fardon, R. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241260989 · Cited by 10
“Notably, the ability of intracerebroventricular OX infusions to reinstate cocaine seeking is reduced by blocking noradrenergic and CRF systems, indicating that OX works in tandem with stress systems to facilitate drug seeking (Boutrel et al., 2005).”
InfluentialSelf-citationPerrey, D. A., Decker, A. M., & Zhang, Y. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00402 · Cited by 10
Reward-Seeking Behavior and Addiction: Cause or Cog?
Arias-Carrión, Ó., & Salama, M. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205030178 · Cited by 10
“Intracerebroventricular (ICV) or local VTA infusions of Hcrt have been shown to reinstate drug-seeking or food-seeking behavior in rodents [125, 126].”
BackgroundWang, D., Zhang, J., Bai, Y., Zheng, X., Alizamini, M. M., Shang, W., Yang, Q., Li, M., Li, Y., & Sui, N. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895521 · Cited by 10
“For example, intra-LH infusion of a Y4 receptor agonist robustly reinstated an extinguished morphine CPP by activating orexin neurons, which have been well-established as the critical LH neurons in drug addiction (Borgland et al., 2006; Boutrel et al., 2005; Harris et al., 2005; Kim et al., 2016).”
BackgroundLeri, F., Zhou, Y., Carmichael, B., Cummins, E., & Kreek, M. J. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.06.003 · Cited by 13
“, 2010) including cocaine seeking (Boutrel et al., 2005).”
BackgroundInteraction Between Orexins and the Mesolimbic System for Overriding Satiety
Hirasawa, M., Parsons, M. P., & Alberto, C. O. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.383 · Cited by 12
Relaciones entre el sueño y la adicción
Cañellas, F., & de Lecea, L. (2012) · Adicciones · doi:10.20882/adicciones.78 · Cited by 10
“Asimismo, estudios en ratas demostraron que la aplicación farmacológica de Hcrt-1 era suficiente para inducir una recaída adictiva (Boutrel et al., 2005).”
BackgroundRisco, S., & Mediavilla, C. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.09.002 · Cited by 10
Stress response pathways, appetite regulation, and drug addiction
Al’Absi, M. (2017) · Biological Psychology · doi:10.1016/j.biopsycho.2017.11.012 · Cited by 9
Orexigenic Hypothalamic Peptides Behavior and Feeding
Davis, J. F., Choi, D. L., & Benoit, S. C. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_24 · Cited by 10
Eat, seek, rest? An orexin/hypocretin perspective
Peleg‐Raibstein, D., Viskaitis, P., & Burdakov, D. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13259 · Cited by 8
Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
Ghanemi, A., & Hu, X. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2014.07.002 · Cited by 10
Black, E. M., Samels, S. B., Xu, W., Barson, J. R., Bass, C. E., Kortagere, S., & España, R. A. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100104 · Cited by 9
Plaza‐Zabala, A., Li, X., Milovanovic, M., Loweth, J. A., Maldonado, R. J., Berrendero, F., & Wolf, M. E. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.038 · Cited by 8
“Conversely, Hcrtr-1 antagonists reduced stress- (12,14), cue- (15,16), and context- (17), but not cocaine-primed (14, 16,18,19), reinstatement of extinguished cocaine-seeking.”
BackgroundCocaine and Nicotine Research Illustrates a Range of Hypocretin Mechanisms in Addiction
Baimel, C., Borgland, S. L., & Corrigall, W. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394623-2.00016-0 · Cited by 8
“Interestingly, cocaine selfadministration is not affected by SB-334867 administration under these conditions (Boutrel et al., 2005; España et al., 2010; Smith et al., 2009).”
BackgroundKoesema, E., & Kodadek, T. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188082 · Cited by 9
Hypocretins (Orexins): Twenty Years of Dissecting Arousal Circuits
Jennings, K. J., & de Lecea, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00001-2 · Cited by 10
Kim, J. S., & Martin‐Fardon, R. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14264 · Cited by 8
“The findings by Boutrel et al. (2005) that central administration of Hcrt-1 reinstated cocaine-seeking behavior in a CRF-dependent manner supports this possibility.”
BackgroundResultSelf-citationZhou, Y., Adomako-Mensah, J., Yuferov, V. P., Ho, A., Zhang, J., Xu, M., & Kreek, M. J. (2006) · Synapse · doi:10.1002/syn.20340 · Cited by 8
“, 2006); and (2) animal studies suggest that the interaction between orexins and their receptors may underlie motivated or seeking behaviors induced by morphine, cocaine, or food (Borgland et al., 2006; Boutrel et al., 2005; Georgescu et al., 2003; Harris et al., 2005).”
Metadata
- Authors
- Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L.
- Affiliations
- Scripps Research Institute (US)
- Center for Psychiatric Neuroscience and Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (SUPEA), Centre Hospitalier Universitaire Vaudois-Département de Psychiatrie (CHUV-DP), University of Lausanne, CH-1008 Prilly, Switzerland; and Departments of Molecular Biology and Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, CA 92037
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-15
- Volume
- 102
- Issue
- 52
- Pages
- 19168-19173
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1323172
- OpenAlex
- W2098772655
- Cited by
- 520
- References
- 48
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 15 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 30 · 2017: 17 · 2016: 27 · 2015: 29 · 2014: 38 · 2013: 33 · 2012: 47
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (1r21aa013241-01)
- National Institute on Alcohol Abuse and Alcoholism (AA13241)
- National Institute of Mental Health (R01MH058543, MH 58543)
- National Institute on Drug Abuse (DA07348, R01DA007348, DA04398, DA 11946, R37DA007348, R56DA011946, R01DA004398, R01DA011946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- orexin-A, orexin, cocaine seeking, reinstatement of drug seeking, stress, noradrenergic system, corticotropin-releasing factor, intracranial self-stimulation, reward systems, addiction, footshock, SB-334867, lateral hypothalamus
- MeSH terms
- Orexins, Analysis of Variance, Animals, Benzoxazoles, Brain, Cocaine, Dose-Response Relationship, Drug, Male, Naphthyridines, Neuropeptides, Reward, Self Administration, Time Factors, Urea, Models, Statistical, Behavior, Addictive, Rats, Wistar, Cocaine-Related Disorders, Intracellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.